ArticleTranslational oncology2024

Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.

Bonnita Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.